We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PII:NYSEPolaris Inc. Analysis

Data as of 2026-05-22 - not real-time

$66.27

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading above its 20‑day SMA but below its 200‑day SMA, indicating a neutral trend. RSI sits in the mid‑50s, suggesting no overbought pressure. MACD histogram remains negative and the signal line is bearish, pointing to short‑term downside risk. Beta above 1.5 and 30‑day volatility near 86% underscore heightened market sensitivity. Volume trend is decreasing, which may limit upside momentum.
The price sits near the identified support of the mid‑50s and well below the DCF‑derived fair value, implying upside potential. Dividend yield is attractive at over 4%, but the payout ratio exceeds 300%, raising sustainability concerns. Recent earnings surprised to the upside, turning a loss into a modest profit and beating consensus. Management raised guidance, reinforcing confidence in revenue growth of roughly 7‑8% YoY. However, operating margins remain negative and debt‑to‑equity is extremely high, highlighting balance‑sheet risk. Overall, the stock presents a blend of value upside with considerable risk, and investors should weigh the strong dividend against sustainability questions and volatile price dynamics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and dividend increase
  • Bearish MACD and decreasing volume
  • High dividend payout ratio raising sustainability concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Price below DCF fair value indicating upside
  • Revenue growth of ~7% YoY
  • Improving margins despite current negatives

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong brand and product portfolio in powersports
  • Cyclical nature of consumer discretionary demand
  • Elevated debt levels and dividend sustainability risk

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin-6.07%
P/E Ratio21.2
ROE-44.85%
ROA0.73%
Debt/Equity292.09
P/B Ratio5.0
Op. Cash Flow$337.6M
Free Cash Flow$350.8M

Technical Analysis

TrendNeutral
RSI56.4
Support$55.85
Resistance$69.43
MA 20$64.87
MA 50$58.89
MA 200$62.22
MACDBearish
VolumeDecreasing
Fear & Greed Index91.54

Valuation

Fair Value$76.59
Target Price$68.00
Upside/Downside2.61%
GradeUndervalued
TypeBlend
Dividend Yield4.10%

Risk Assessment

Beta1.60
Volatility86.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.